This inventor holds 1 USPTO granted patent. Top assignee: Suzhou Pharmavan Cancer Research Center Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Chuangliang Jiang: Innovator in Pharmaceutical Research
Introduction
Chuangliang Jiang is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of treatments for autoimmune diseases and tumors. His innovative work has the potential to impact the lives of many patients suffering from difficult-to-treat conditions.
Latest Patents
Chuangliang Jiang holds a patent for a glaucocalyxin A derivative and its preparation method and application. This patent, which is represented by the formula (I), outlines a method for preparing the glaucocalyxin A derivative and its use in pharmaceuticals aimed at combating autoimmune diseases and tumors. Notably, this includes challenging diseases such as systemic lupus erythematosus, psoriasis, and triple-negative breast cancer. He has 1 patent to his name.
Career Highlights
Chuangliang Jiang is associated with the Suzhou Pharmavan Cancer Research Center Co., Ltd. His work at this institution focuses on advancing cancer research and developing innovative therapeutic solutions. His dedication to improving patient outcomes through scientific research is commendable.
Collaborations
Chuangliang Jiang collaborates with esteemed colleagues, including Rensen Zhou and Yunhui Yu. Their combined expertise enhances the research efforts at the Suzhou Pharmavan Cancer Research Center, fostering an environment of innovation and discovery.
Conclusion
Chuangliang Jiang is a notable inventor whose work in pharmaceutical research is paving the way for new treatments for serious health conditions. His contributions are vital to the ongoing fight against autoimmune diseases and tumors, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile